Skip to main content
. 2019 Sep 23;4:37. doi: 10.1038/s41392-019-0071-8

Table 2.

Current status of selected AD drugs in clinical trials

Drug Developer Mechanism of action Stage NCT number
(https://clinicaltrials.gov)

AAB-003

(PF‑05236812)

Janssen/Pfizer Aβ-specific mAb

Phase I

(completed)457

NCT01193608
GV-971 Shanghai Green Valley Pharmaceutical Co., Ltd. Mannose oligosaccharide diacid

Phase III

(completed in China)

NCT02293915